A Prognostic Gene Expression Profile That Predicts Circulating Tumor Cell Presence in Breast Cancer Patients

por Molloy, Timothy J., Roepman, Paul, Naume, Bjørn, van't Veer, Laura J.
Publicado 2012

A comparison of univariate and multivariate gene selection techniques for classification of cancer datasets

por Lai, Carmen, Reinders, Marcel JT, van't Veer, Laura J, Wessels, Lodewyk FA
Publicado 2006

Withdrawal from Genetic Counselling for Cancer

por Bleiker, Eveline, Wigbout, Gea, van Rens, Anja, Verhoef, Senno, van't Veer, Laura, Aaronson, Neil
Publicado 2005

Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity

por Wolf, Denise M., Lenburg, Marc E., Yau, Christina, Boudreau, Aaron, van ‘t Veer, Laura J.
Publicado 2014

Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma

por Curl, Patti, Vujic, Igor, van ‘t Veer, Laura J., Ortiz-Urda, Susana, Kahn, James G.
Publicado 2014

Correction: Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma

por Curl, Patti, Vujic, Igor, van ‘t Veer, Laura J., Ortiz-Urda, Susana, Kahn, James G.
Publicado 2015

Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy

por Magbanua, Mark Jesus M., Gumusay, Ozge, Kurzrock, Razelle, van ‘t Veer, Laura J., Rugo, Hope S.
Publicado 2022

Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer

por Tian, Sun, Roepman, Paul, van’t Veer, Laura J, Bernards, Rene, de Snoo, Femke, Glas, Annuska M
Publicado 2010

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance

por Stejskal, Pavel, Goodarzi, Hani, Srovnal, Josef, Hajdúch, Marián, van ’t Veer, Laura J., Magbanua, Mark Jesus M.
Publicado 2023

Comparison of prognostic gene expression signatures for breast cancer

por Haibe-Kains, Benjamin, Desmedt, Christine, Piette, Fanny, Buyse, Marc, Cardoso, Fatima, van't Veer, Laura, Piccart, Martine, Bontempi, Gianluca, Sotiriou, Christos
Publicado 2008

A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction

por Tian, Sun, Simon, Iris, Moreno, Victor, Roepman, Paul, Tabernero, Josep, Snel, Mireille, van't Veer, Laura, Salazar, Ramon, Bernards, Rene, Capella, Gabriel
Publicado 2013

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis

por van den Broek, Alexandra J., Schmidt, Marjanka K., van ‘t Veer, Laura J., Tollenaar, Rob A. E. M., van Leeuwen, Flora E.
Publicado 2015

Expression profiling predicts outcome in breast cancer

por van 't Veer, Laura J, Dai, Hongyue, van de Vijver, Marc J, He, Yudong D, Hart, Augustinus AM, Bernards, René, Friend, Stephen H
Publicado 2003

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients

por Crawford, Beth, Adams, Sophie B., Sittler, Taylor, van den Akker, Jeroen, Chan, Salina, Leitner, Ofri, Ryan, Lauren, Gil, Elad, van ’t Veer, Laura
Publicado 2017

The spectrum of ATM missense variants and their contribution to contralateral breast cancer

por Broeks, Annegien, Braaf, Linde M., Huseinovic, Angelina, Schmidt, Marjanka K., Russell, Nicola S., van Leeuwen, Flora E., Hogervorst, Frans B. L., Van ‘t Veer, Laura J.
Publicado 2007

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype

por Ruijs, Marielle WG, Broeks, Annegien, Menko, Fred H, Ausems, Margreet GEM, Wagner, Anja, Oldenburg, Rogier, Meijers-Heijboer, Hanne, van't Veer, Laura J, Verhoef, Senno
Publicado 2009

The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients

por Molloy, Timothy J, Bosma, Astrid J, Baumbusch, Lars O, Synnestvedt, Marit, Borgen, Elin, Russnes, Hege Giercksky, Schlichting, Ellen, van't Veer, Laura J, Naume, Bjørn
Publicado 2011

The Prognostic Implications of Macrophages Expressing Proliferating Cell Nuclear Antigen in Breast Cancer Depend on Immune Context

por Campbell, Michael J., Wolf, Denise, Mukhtar, Rita A., Tandon, Vickram, Yau, Christina, Au, Alfred, Baehner, Frederick, van’t Veer, Laura, Berry, Donald, Esserman, Laura J.
Publicado 2013

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk

por van ‘t Veer, Laura J., Yau, Christina, Yu, Nancy Y., Benz, Christopher C., Nordenskjöld, Bo, Fornander, Tommy, Stål, Olle, Esserman, Laura J., Lindström, Linda Sofie
Publicado 2017

Gene Expression Profiles from Formalin Fixed Paraffin Embedded Breast Cancer Tissue Are Largely Comparable to Fresh Frozen Matched Tissue

por Mittempergher, Lorenza, de Ronde, Jorma J., Nieuwland, Marja, Kerkhoven, Ron M., Simon, Iris, Th. Rutgers, Emiel J., Wessels, Lodewyk F. A., Van't Veer, Laura J.
Publicado 2011